These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3626885)

  • 1. Pharmacological studies with (7 alpha,17 alpha)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14).
    van der Vies J
    Maturitas; 1987; Suppl 1():15-24. PubMed ID: 3626885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrinological studies with (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14).
    de Visser J; Coert A; Feenstra H; van der Vies J
    Arzneimittelforschung; 1984; 34(9):1010-7. PubMed ID: 6542369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile of Org OD 14.
    Tax L; Goorissen EM; Kicovic PM
    Maturitas; 1987; Suppl 1():3-13. PubMed ID: 3306290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis.
    Geusens P; Dequeker J; Gielen J; Schot LP
    Maturitas; 1991 Jun; 13(2):155-62. PubMed ID: 1921738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and post-menopausal women.
    Genazzani AR; Petraglia F; Facchinetti F; Genazzani AD; Bergamaschi M; Grasso A; Volpe A
    Maturitas; 1987; Suppl 1():35-48. PubMed ID: 2957569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human endometrial 3 beta-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14).
    Tang B; Markiewicz L; Kloosterboer HJ; Gurpide E
    J Steroid Biochem Mol Biol; 1993 May; 45(5):345-51. PubMed ID: 8499344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrinological studies with desogestrel.
    van der Vies J; de Visser J
    Arzneimittelforschung; 1983; 33(2):231-6. PubMed ID: 6221730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomized women.
    Punnonen R; Liukko P; Cortes-Prieto J; Eydam F; Milojevic S; Trévoux R; Chryssikopoulos E; Franchi F; Luisi M; Kicovic PM
    Maturitas; 1984 Apr; 5(4):281-6. PubMed ID: 6738375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.
    Kasugai Y; Ikegami A; Matsuo K; Ohashi M; Sukamoto T; Hosoi T; Ouchi Y; Orimo H
    Bone; 1998 Feb; 22(2):119-24. PubMed ID: 9477234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of Org OD 14 and 17 beta-oestradiol on bone and lipid metabolism in early post-menopausal women.
    Netelenbos JC; Siregar-Emck MT; Schot LP; van Ginkel FC; Lips P; Leeuwenkamp OR
    Maturitas; 1991 Jun; 13(2):137-49. PubMed ID: 1921737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of Org OD 14 on lipid metabolism in post-menopausal women.
    Kloosterboer HJ; Benedek-Jaszmann LJ; Kicovic PM
    Maturitas; 1990 Apr; 12(1):37-42. PubMed ID: 2333035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats.
    Ederveen AG; Kloosterboer HJ
    J Bone Miner Res; 1999 Nov; 14(11):1963-70. PubMed ID: 10571697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo.
    Crona N; Samsioe G; Lindberg UB; Silfverstolpe G
    Maturitas; 1988 Mar; 9(4):303-8. PubMed ID: 3288845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nestorone: a progestin with a unique pharmacological profile.
    Kumar N; Koide SS; Tsong Y; Sundaram K
    Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives.
    Schoonen WG; Deckers GH; de Gooijer ME; de Ries R; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 2000 Nov; 74(4):213-22. PubMed ID: 11162927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A; Hahn DW; McGuire JL
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation, synthesis, and biological activity of five metabolites of danazol.
    Rosi D; Neumann HC; Christiansen RG; Schane HP; Potts GO
    J Med Chem; 1977 Mar; 20(3):349-52. PubMed ID: 403283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Org OD 14 and the endometrium.
    Genazzani AR; Benedek-Jaszmann LJ; Hart DM; Andolsek L; Kicovic PM; Tax L
    Maturitas; 1991 Sep; 13(3):243-51. PubMed ID: 1943832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological assay of progestinics and antiprogestinics].
    Chambon Y
    Therapie; 1968; 23(4):703-35. PubMed ID: 4314722
    [No Abstract]   [Full Text] [Related]  

  • 20. The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites.
    Lemus AE; Zaga V; Santillán R; García GA; Grillasca I; Damián-Matsumura P; Jackson KJ; Cooney AJ; Larrea F; Pérez-Palacios G
    J Endocrinol; 2000 Jun; 165(3):693-702. PubMed ID: 10828854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.